Evidence map›Paper›PMID 28031426›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer.

Ganesh S Palapattu, Simpa S Salami, Andi K Cani, Daniel H Hovelson, Lorena Lazo de la Vega, Kelly R Vandenberg, Jarred V Bratley, Chia-Jen Liu, Lakshmi P Kunju, Jeffery S Montgomery and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. MR Imaging/Ultrasound Fusion-Guided Biopsy and Primary Focal Therapy for Localized Prostate Cancer.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2026
    Review
  2. Histopathologic and Molecular Characterization of IDH-Mutant Prostatic Adenocarcinoma.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Observational
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ganesh S PalapattuDepartment of Urology, University of Michigan, Ann Arbor, Michigan. gpalapat@med.umich.edu tomlinss@med.umich.edu LMarks@mednet.ucla.edu.
Simpa S SalamiDepartment of Urology, University of Michigan, Ann Arbor, Michigan.
Andi K CaniDepartment of Pathology, Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
Daniel H HovelsonComputational Medicine & Bioinformatics, University of Michigan, Ann Arbor, Michigan.
Lorena Lazo de la VegaDepartment of Pathology, Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
Kelly R VandenbergDepartment of Pathology, Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
Jarred V BratleyDepartment of Pathology, Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
Chia-Jen LiuDepartment of Pathology, Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
Lakshmi P KunjuDepartment of Pathology, Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
Jeffery S MontgomeryDepartment of Urology, University of Michigan, Ann Arbor, Michigan.
Todd M MorganDepartment of Urology, University of Michigan, Ann Arbor, Michigan.
Shyam NatarajanDepartment of Urology, David Geffen School of Medicine at UCLA, Los Angeles, California.
Jiaoti HuangDepartment of Pathology, Duke University School of Medicine, Durham, North Carolina.
Scott A TomlinsDepartment of Urology, University of Michigan, Ann Arbor, Michigan. gpalapat@med.umich.edu tomlinss@med.umich.edu LMarks@mednet.ucla.edu.
Leonard S MarksDepartment of Urology, David Geffen School of Medicine at UCLA, Los Angeles, California. gpalapat@med.umich.edu tomlinss@med.umich.edu LMarks@mednet.ucla.edu.

Funding

Tissue/InformaticsP50CA186786 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Robert Timothy Dess · 2014 to 2026
$27.6M
Biopsy Tracking and MRI Fusion to Enhance Imaging of Cancer Within the ProstateR01CA158627 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MARKS, LEONARD STEPHEN · 2011 to 2013
$1.4M
NCI NIH HHS P50 CA186786NCI NIH HHS R01 CA158627
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedBiopsyClonal EvolutionHigh-Throughput Nucleotide SequencingHumansMagnetic Resonance ImagingMaleMiddle AgedMutationNeoplasm GradingNeoplasm ProteinsProstatic NeoplasmsUltrasonographyNeoplasm Proteins

Identifiers

PMID28031426
PMCPMC5315613

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.